Obstetrics & Gynecology · Paramus, NJ
NPI
1114121571
Since 2007
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1 Kalisa Way Ste 103
Paramus, NJ, 07652
Phone (201) 301-2772
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
389 services
Medicare patients, 2024
126
Average age 74
Drug cost, 2024
$186K
698 prescriptions
Company payments, 2025
$367
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khashayar Shakiba was code 99213 (office e&m - established), 164 times for 81 patients. In total Khashayar Shakiba billed 389 services in 33 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 164 | 81 | $68.92 | $11K |
| 99214 Office E&M - Established | Office | 50 | 28 | $105.83 | $5,291 |
| G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | Office | 34 | 11 | $7.98 | $271 |
| 99204 Office E&M - New | Office | 12 | 12 | $125.06 | $1,501 |
By year: 2022 $95K for 912 services; 2023 $63K for 706 services; 2024 $41K for 389 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khashayar Shakiba prescribed most often to Medicare patients was Gemtesa (Vibegron), with 89 prescriptions and refills. In total Khashayar Shakiba wrote 698 Medicare prescriptions that cost $186K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gemtesa Vibegron | 89 | 183 | 23 | $85K |
| Estradiol Generic | 84 | 186 | 39 | $5,444 |
| Hydroxyzine Pamoate Generic | 69 | 87 | 25 | $353 |
| Myrbetriq Mirabegron | 67 | 78 | 12 | $37K |
| Intrarosa Prasterone (Dhea) | 61 | 71 | 32 | $18K |
| Hydroxyzine Hcl Generic | 43 | 59 | 17 | $345 |
| Gabapentin Generic | 34 | 34 | 13 | $178 |
| Premarin Estrogens, Conjugated | 33 | 59 | 18 | $14K |
| Methenamine Hippurate Generic | 28 | 45 | Under 11 | $1,417 |
| Triamcinolone Acetonide Generic | 26 | 26 | 15 | $219 |
| Estring Estradiol | 25 | 75 | Under 11 | $13K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 16 | 16 | 14 | $186 |
| Fluconazole Generic | 14 | 15 | 12 | $106 |
| Ciprofloxacin Hcl Generic | 14 | 14 | 13 | $54.93 |
| Clobetasol Propionate Generic | 13 | 13 | Under 11 | $436 |
Brand drugs: 303 claims; generic drugs: 395 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khashayar Shakiba $367 ($367 in general payments such as food, travel and fees) from 10 companies. The largest payer was Biotissue Holdings Inc. with $139.
| Company | Payments | Amount |
|---|---|---|
| Biotissue Holdings Inc. | 1 | $139 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $56.64 |
| Hikma Pharmaceuticals USA HIK.L | 2 | $38.11 |
| Abbvie Inc. ABBV | 1 | $27.58 |
| ABC Home Medical Supply, Inc. | 1 | $20.15 |
| Millicent US Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.99 |
| Astellas Pharma US Inc 4503.T | 1 | $17.65 |
| Coloplast Corp | 1 | $15.58 |
| Amgen Inc. AMGN | 1 | $15.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.